SSRIs for PMDD: Luteal-Phase vs. Continuous Dosing

Most people assume an antidepressant is something you take every single day. For premenstrual dysphoric disorder, that assumption doesn't always hold, and the reason is one of the more surprising facts about treating it.

Because PMDD symptoms are tied to the menstrual cycle, an SSRI for PMDD can be taken in two different ways: every day (continuous dosing), or only during the roughly two weeks before your period (luteal-phase, sometimes called intermittent, dosing). Both are legitimate, evidence-backed approaches, and which one fits depends on your cycle, your symptoms, and your preferences.

Why PMDD allows part-time dosing

For depression or an anxiety disorder, an SSRI has to build up over several weeks before it helps, so daily use is the only option. PMDD behaves differently. SSRIs tend to work unusually fast here, often within a day or two of starting, which is what makes it possible to take the medication only when symptoms are due, then stop once the period arrives. The same biology that makes PMDD so tightly cycle-linked is what opens the door to dosing it part-time.

The two approaches

Continuous dosing means taking the SSRI every day, all month. It's the simplest to remember, keeps a steady level in your system, and is the better choice if your cycles are irregular or if you also have symptoms outside the premenstrual window, such as low mood or anxiety that runs all month.

Luteal-phase dosing means starting the SSRI about 14 days before your expected period (or at the first sign of symptoms each cycle) and stopping at or shortly after menstruation begins. The appeal is less total medication, fewer cumulative side effects, and no continuous daily exposure. The trade-off is that it asks for fairly predictable cycles and the discipline to start on time each month.

Which approach works better?

Here's the honest answer: the evidence is genuinely mixed. A 2024 Cochrane review found SSRIs effective for PMDD overall and suggested continuous dosing may have a slight edge over luteal-only dosing, though the certainty was moderate (Jespersen et al., 2024). A 2023 meta-analysis comparing the two directly found no significant difference between intermittent and continuous dosing in response, dropout, or symptom scores (Reilly et al., 2023). So neither is clearly superior for everyone, which is good news, because it means the choice can be made around your life rather than forced by the data.

Which SSRIs are used

Three SSRIs are specifically FDA-approved for PMDD: fluoxetine, sertraline, and controlled-release paroxetine, though others are used as well (Medscape). The choice among them comes down to side-effect profile, half-life, and how you respond, which is a conversation with your prescriber. For a sense of how SSRIs feel when starting, our piece on how long an SSRI takes to work is a useful companion, keeping in mind that PMDD onset is usually quicker.

Side effects and stopping

One practical advantage of luteal dosing is less cumulative exposure, and trials using it haven't shown the kind of withdrawal seen with daily long-term use. With continuous dosing, the usual rule applies: don't stop abruptly, since that can cause discontinuation symptoms, so any change is tapered with your prescriber. Either way, side effects in the first cycle or two often settle as your body adjusts.

How to choose

A rough guide: if your cycles are predictable and your symptoms are confined to the premenstrual window, luteal-phase dosing is worth discussing. If your cycles are irregular, you also have symptoms across the whole month, or remembering to start each cycle feels like one more thing to fail at, continuous dosing is often the steadier choice. There's no wrong answer here: both treat premenstrual dysphoric disorder effectively, and you can switch if the first approach isn't a good fit.

If your premenstrual symptoms ever include thoughts of harming yourself, please don't wait for the next cycle. Call or text 988, the Suicide & Crisis Lifeline, any time.

Book your first evaluation to talk through which dosing approach makes sense for your situation.

If any of this sounds familiar, you don't have to sort it out alone - book your first evaluation and we'll take it from there.